After eight years as vice provost for research, John Bixby, Ph.D., who laid the foundation for the University of Miami’s burgeoning culture of interdisciplinary collaboration, plans to step down as vice provost next June and will work closely with his successor, Erin Kobetz, Ph.D., M.P.H., the associate director for population science and cancer disparity at Sylvester Comprehensive Cancer Center, until then.
Dr. Bixby will gradually transition the vice provost for research duties over the next nine months, while Dr. Kobetz’s responsibilities increase. Dr. Kobetz will serve as co-vice provost for research, assuring a smooth transition in the Office of the Vice Provost for Research in its critical mission of fostering the highest quality research and creative activities to advance knowledge and address regional, national, and global society needs.
The U.S. Department of Health and Human Services’ Office of Research Integrity has awarded the University of Miami the second in a series of grants to help foster academic research integrity in Latin America. The award, announced on September 8, builds on the UM Institute for Bioethics and Health Policy’s initiatives over more than a quarter century to build partnerships and develop educational resources across Latin America.
The $300,000 Hyundai Scholar Hope Grant, awarded to Sylvester Comprehensive Cancer Center, is helping to fund the future of precision medicine in pediatric patients with metastatic sarcoma. Sarcoma is a type of cancer that typically occurs in the bone or soft tissue. Sarcomas can be seen in pediatric, adolescent and young adult patients, with a peak incidence in the adolescent and young adult population.
Surgeons have treated a patient’s “dead” ankle bone with a custom, 3D-printed replacement for the first time at UHealth Tower and the University of Miami Miller School of Medicine. It was a “Terminator-style, 21st Century approach” to helping the 24-year-old patient, said Amiethab Aiyer, M.D., a UHealth orthopedic surgeon specializing in foot and ankle surgery.
A laboratory study by University of Miami Miller School of Medicine researchers could lead to a new treatment strategy for Huntington’s disease, an incurable genetic disorder. “We discovered the neuroprotective role of a cellular ‘housekeeping’ enzyme in alleviating disease progression,” said R. Grace Zhai, Ph.D., associate professor of molecular and cellular pharmacology.
Back in 2001, when the Miller School of Medicine held its first freshman pinning ceremony, Alex J. Mechaber, M.D., a young faculty member and a double UM alumnus, delivered the keynote address welcoming the Class of 2005 to “our noble profession.”